ViaCyte Names General Counsel

San Diego-based ViaCyte, a clinical-stage regenerative medicine company, said today that it has named Marty Lorenzo as General Counsel. Lorenzo previously was Vice President Legal Affairs and Assistant Corporate Secretary at Petco. Lorenzo also previously served at DLA Piper, Mintz Levin, and Kilpatrick Townsend. The company says its first product candidates are being developed as potential long-term treatments for patients with type 1 diabetes to achieve glucose control targets and reduce the risk of hypoglycemia and diabetes-related complications.